Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AbbVie Resource Report Resource Website 500+ mentions |
AbbVie (RRID:SCR_010484) | ABBV | commercial organization | A research-based biopharmaceutical company that develops advanced therapies to address global health problems. | pharmaceutical, advanced therapy, biopharmaceutical, research, global health, commercial organization |
is related to: Kidney Health Initiative is related to: Structural Genomics Consortium is related to: Alzheimers Association Research Roundtable is related to: Abbott is related to: Abbott is related to: NEWMEDS is related to: ORBITO is related to: PREDECT |
nlx_158067, grid.472726.2 | https://ror.org/024e28c54 | SCR_010484 | AbbVie Inc., AbbVie Deutschland GmbH & Co KG, AbbVie Deutschland GmbH and Co KG | 2026-08-29 11:23:31 | 916 | |||||||
|
NEWMEDS Resource Report Resource Website 1+ mentions |
NEWMEDS (RRID:SCR_003872) | NEWMEDS | consortium, data or information resource, organization portal, portal | Consortium that will develop new models and methods to enable novel treatments for schizophrenia and depression including three important missing tools that will facilitate the translation of scientific findings into benefits for patients. The project will focus on developing new animal models which use brain recording and behavioral tests to identify innovative and effective drugs for schizophrenia. The project will develop standardized paradigms, acquisition and analysis techniques to apply brain imaging, especially fMRI and PET imaging to drug development. It will examine how new genetic findings (duplication and deletion or changes in genes) influence the response to various drugs and whether this information can be used to choose the right drug for the right patient. And finally, it will try and develop new approaches for shorter and more efficient trials of new medication - trials that may require fewer patients and give faster results. | drug, biomarker, neuroimaging, drug development, tool development, animal model, fmri, pet, gene, medicine, clinical trial, genetic variation, molecule, model, dna, protein |
is listed by: Consortia-pedia is related to: Abbott Diagnostics is related to: Janssen Research and Development is related to: Orion is related to: Pfizer Animal Genetics is related to: Roche is related to: King's College London; London; United Kingdom is related to: Karolinska Institute; Stockholm; Sweden is related to: University of Cambridge; Cambridge; United Kingdom is related to: Central Institute of Mental Health; Mannheim; Germany is related to: Spanish National Research Council; Madrid; Spain is related to: University of Manchester; Manchester; United Kingdom is related to: Bar-Ilan University; Ramat Gan; Isreal is related to: Psynova Neurotech is related to: deCODE genetics is related to: GABO:mi is related to: AbbVie has parent organization: King's College London; London; United Kingdom is parent organization of: DepressionTools.org Clinical Significance Calculator is parent organization of: Pharmacological Imaging and Pattern Recognition toolbox is parent organization of: DUPCheck |
Innovative Medicines Initiative 115008; EFPIA |
nlx_158196 | SCR_003872 | Novel Methods leading to New Medications in Depression and Schizophrenia, NEWMEDS - Novel Methods leading to New Medications in Depression and Schizophrenia | 2026-08-29 11:22:01 | 6 | |||||||
|
Kidney Health Initiative Resource Report Resource Website |
Kidney Health Initiative (RRID:SCR_003869) | KHI | consortium, data or information resource, organization portal, portal | Consortium that brings together the kidney community (patient advocacy groups, industry, government agencies, and professional organizations) to overcome existing challenges, including regulatory and nonregulatory barriers, and optimize the development and safety of products that impact kidney health including drugs, devices, biologics, and food products. The goals of the consortium are to: * Facilitate dialogue and research that informs regulatory processes with regard to the kidney health of patients being treated for kidney-related as well as other diseases. * Assess current medical therapies and diagnostics to identify areas in need of greater innovation and/or better defined regulatory pathways. * Develop innovative and efficient trial designs appropriate to answer the most important questions related to kidney health. * Establish expert consensus around common terminology and key definitions related to kidney health. * Develop approaches to the systematic collection of retrospective or prospective data, such as registries and/or global databases, and establishment of data standards. * Coordinate think tanks, public forums, educational exchanges, and other events to promote discussion and updates on topics in kidney health pertaining to drug, device, biologics, and food product development and evaluation. * Create transparent infrastructure and processes that facilitate collaboration and communication among the greater nephrology community and the FDA, including: * Seek input from all stakeholders (including nephrologists and other health professionals, patient groups, industry, the National Institutes of Health, the Centers for Medicare and Medicaid Services, the Health Resources and Services Administration, and other federal agencies). * Leverage previously conducted and ongoing clinical studies, research infrastructure, and databases. * Create an open and efficient mechanism for encouraging and objectively evaluating potential projects submitted to KHI. * Involve consortium members in the selection and execution of projects. * Establish systems to optimize post-market surveillance of products that affect kidney health, either intentionally or via adverse drug reactions. * Author journal articles and white papers regarding key issues, describing opportunities and challenges and proposing solutions, as well as promoting execution of these solutions. | device development, drug development, tool development, basic research, drug, device, biologics, food product, kidney, data standard, nephrology, safety, innovation, public health |
is listed by: Consortia-pedia is related to: AbbVie is related to: American Association of Kidney Patients is related to: American College of Clinical Pharmacy is related to: American Nephrology Nurses Association is related to: American Society for Apheresis is related to: American Society of Diagnostic and Interventional Nephrology is related to: ASN - American Society of Nephrology is related to: American Society of Pediatric Nephrology is related to: American Society of Transplantation is related to: Anthera Pharmaceuticals is related to: Arbor Research Collaborative for Health is related to: Association for the Advancement of Medical Instrumentation is related to: Baxter is related to: C. R. Bard is related to: ChemoCentryx is related to: ClinMet is related to: University of Oxford; Oxford; United Kingdom is related to: DaVita is related to: Dialysis Patient Citizens is related to: Duke University School of Medicine; North Carolina; USA is related to: ERA-EDTA is related to: FAST BioMedical is related to: Shire is related to: Home Dialyzors United is related to: Hospira is related to: All India Institute of Medical Sciences; New Delhi; India is related to: Juvenile Diabetes Research Foundation is related to: Karolinska Institute; Stockholm; Sweden is related to: University of Washington; Seattle; USA is related to: Mallinckrodt Pharmaceuticals is related to: MediBeacon is related to: Medtronic is related to: National Kidney Foundation is related to: National Renal Administrators Association is related to: NephCure Kidney International is related to: Nephrology Nursing Certification Commission is related to: Nephropath is related to: NxStage Medical is related to: OPKO is related to: Otsuka America Pharmaceutical Inc. is related to: Pfizer Animal Genetics is related to: PKD Foundation is related to: Proteon Therapeutics is related to: Puracath Medical is related to: Quintiles is related to: Reata Pharmaceuticals is related to: Relypsa is related to: Renal Physicians Association is related to: Renal Support Network is related to: Rockwell Medical is related to: St. Marianna University School of Medicine; Kawasaki; Japan is related to: Binding Site is related to: George Institute for Global Health is related to: Thrasos Therapeutics is related to: Vascular Access Society is related to: Vascular Access Society of the Americas is related to: Vascular Therapies is related to: Vasculitis Foundation is related to: W. L. Gore and Associates is related to: U.S. Food and Drug Administration has parent organization: ASN - American Society of Nephrology has parent organization: U.S. Food and Drug Administration has parent organization: Agency for Healthcare Research and Quality has parent organization: Centers for Medicare and Medicaid Services has parent organization: National Institutes of Health |
U.S. Food and Drug Administration ; Membership dues |
nlx_158194 | SCR_003869 | Kidney Health Initiative (KHI) | 2026-08-29 11:22:01 | 0 | |||||||
|
PREDECT Resource Report Resource Website 1+ mentions |
PREDECT (RRID:SCR_003883) | PREDECT | consortium, data or information resource, organization portal, portal | Project that aims to create more appropriate in vitro platforms for target validation and drug discovery for breast, prostate and lung cancers. Laboratory platforms to validate whether target modulation would provide a clinical benefit are usually highly reductionist, often using long-established cell lines growing in 2 dimensions in vitro. These models do not reflect the complexity and heterogeneity of a tumor in situ, where biochemical pathways are wired with connections to the complex tumor environment provided by the stroma. PREDECT has the goal of comparing the pathological and molecular profiles of novel in vitro platforms with those of human tumors. Because obtention of clinical material presents both logistics and quality problems for ongoing and intense studies of target validation, PREDECT aims to use material from genetically engineered mouse models, and some advanced xenografts, whose pathology and molecular profiles closely match cohorts of human tumors. PREDECT hopes to provide more appropriate in vitro platforms both for target validation and subsequent preclinical studies which will replace a current cascade of tests which are poorly predictive of clinical activity. The project is expected to shift paradigms in cell biology as well as in preclinical target validation where it should permit greater predictivity of drug efficacy in patient cohorts. | drug, oncology, drug development, basic research, in vitro, xenograft, breast, prostate, lung, pre-clinical, target validation, drug discovery |
is listed by: Consortia-pedia is related to: Roche is related to: Orion is related to: sigma-tau is related to: Janssen Research and Development is related to: AbbVie is related to: Institute of Cancer Research is related to: Ecole Polytechnique Federale de Lausanne; Lausanne; Switzerland is related to: VTT Technical Research Centre of Finland is related to: University of Helsinki; Helsinki; Finland is related to: University of Tartu; Tartu; Estonia is related to: Biomedicum Genomics is related to: Oncotest is related to: Institute of Experimental Biology and Technology; Oeiras; Portugal is related to: Cardiff University; Wales; United Kingdom has parent organization: University of Helsinki; Helsinki; Finland |
Innovative Medicines Initiative ; EFPIA |
nlx_158212 | SCR_003883 | Preclinical evaluation of drug efficacy in common solid tumours, Predect New models for preclinical evaluation of drug efficacy in common solid tumours | 2026-08-29 11:22:01 | 8 | |||||||
|
Structural Genomics Consortium Resource Report Resource Website 50+ mentions |
Structural Genomics Consortium (RRID:SCR_003890) | SGC | consortium, data or information resource, organization portal, portal | Charity registered in United Kingdom whose mission is to accelerate research in new areas of human biology and drug discovery.Not for profit, public-private partnership that carries out basic science of relevance to drug discovery whose core mandate is to determine 3D structures on large scale and cost effectively targeting human proteins of biomedical importance and proteins from human parasites that represent potential drug targets. | basic science, drug discovery, drug, structural genomics, genomics, 3d structure, protein, human parasite, drug target, structure, human protein, protocol, phylogenetic tree, histone tail, high-throughput protein crystallization, lex bubbling system, reagent, epigenetic probe, antibody, vector, plasmid, construct |
uses: Research Collaboratory for Structural Bioinformatics Protein Data Bank (RCSB PDB) uses: Addgene uses: GenBank is related to: AbbVie is related to: Canada Foundation for Innovation is related to: Canadian Institutes of Health Research is related to: Genome Canada is related to: Janssen Research and Development is related to: Ontario Ministry of Economic Development Employment and Infrastructure is related to: Pfizer Animal Genetics is related to: Wellcome Trust has parent organization: University of Oxford; Oxford; United Kingdom has parent organization: University of Toronto; Ontario; Canada |
Cancer, Diabetes, Obesity, Psychiatric disorder, Altzheimer | AbbVie ; Boehringer Ingelheim ; Canada Foundation for Innovation ; Canadian Institutes of Health Research ; Genome Canada ; GlaxoSmithKline ; Janssen ; Lilly Canada ; Novartis Research Foundation ; Ontario Ministry of Economic Development Employment and Infrastructure ; Pfizer ; Takeda ; Wellcome Trust |
Restricted | nlx_158220 | SCR_003890 | Structural Genomics Consortium | 2026-08-29 11:22:01 | 65 | |||||
|
ORBITO Resource Report Resource Website 1+ mentions |
ORBITO (RRID:SCR_003876) | ORBITO | consortium, data or information resource, organization portal, portal | Project that aims to increase understanding of how orally-administered drugs are taken up from the gastrointestinal tract into the body, and apply this knowledge to create new laboratory tests and computer models that will better predict the performance of these drugs in patients over a range of clinically relevant conditions. The integration of in vitro and in silico approaches will provide a biopharmaceutics toolkit, validated using clinical data, to accelerate drug development. Ultimately, the project will help to facilitate and speed up the formulation development process and significantly reduce the need for animal experiments in this area as well as for human clinical studies in the future. For patients, the main benefit will be in the form of high quality medicines where the dose required is well calculated and is released in a way that consistently provides an optimal clinical effect. | drug, drug development, tool development, computer model, drug absorption, oral drug, gastrointestinal tract, clinical, in vivo, in vitro, in silico, biopharmaceutics, dose, drug performance |
is listed by: Consortia-pedia is related to: AbbVie is related to: Janssen Research and Development is related to: Merck is related to: Orion is related to: Pfizer Animal Genetics is related to: Uppsala University; Uppsala; Sweden is related to: University of Copenhagen; Copenhagen; Denmark is related to: University of Greifswald; Mecklenburg-Vorpommern; Germany is related to: Goethe University Frankfurt am Main; Hessen; Germany is related to: Johannes Gutenberg University Mainz; Rhineland-Palatinate; Germany is related to: Catholic University of Leuven; Flemish Brabant; Belgium is related to: Medical Products Agency; Uppsala; Sweden is related to: University of Athens; Athens; Greece is related to: TNO is related to: University of Manchester; Manchester; United Kingdom is related to: University of Strathclyde; Glasgow; United Kingdom is related to: Simcyp is related to: Sirius Analytical is related to: Simulations Plus has parent organization: Uppsala University; Uppsala; Sweden |
Innovative Medicines Initiative ; EFPIA |
nlx_158204 | SCR_003876 | orbito - Innovative Tools for Oral Biopharmaceutics, Oral biopharmaceutics tools (ORBITO) | 2026-08-29 11:21:41 | 7 | |||||||
|
Alzheimers Association Research Roundtable Resource Report Resource Website |
Alzheimers Association Research Roundtable (RRID:SCR_004007) | Research Roundtable | consortium, data or information resource, meeting resource, organization portal, portal, training resource | A consortium aiming to facilitate the development and implementation of new treatments for Alzheimer's disease by collectively addressing obstacles to research and development, clinical care and public health education. The Roundtable convenes twice each year for a two-day presentation and discussion of specific topics within Alzheimer's research. Topics are selected from a list proposed and voted on by members. Roundtable members explore a broad range of Alzheimer's science topics, including: * New data and technologies that may improve the diagnosis of Alzheimer's disease, especially in its earliest and mildest stages. * Neuropsychological testing, genetic factors, and biochemical and neuroimaging biomarkers that could contribute to an earlier and more accurate Alzheimer's diagnosis. * Lessons learned about clinical trial design that may help shape future clinical trials of drugs aimed at slowing or stopping the progression of Alzheimer's. * The pros and cons of various scales as outcomes measures of clinical trials. The outputs of Roundtable meetings are published as articles in the Alzheimer's Association's journal, Alzheimer's & Dementia. The Research Roundtable also sponsors Alzheimer's Association grants. The chosen project is named Research Roundtable Sponsored Grant and the principal investigator of the project is invited to give a progress report at a Roundtable meeting. | drug, drug development, tool development, product development, discussion, funding resource, diagnosis, neuropsychological testing, genetic, biochemical, neuroimaging, clinical trial, outcome |
is listed by: Consortia-pedia is related to: AbbVie has parent organization: Alzheimers Association |
nlx_158423 | SCR_004007 | Alzheimer's Association Research Roundtable | 2026-08-29 11:22:03 | 0 | ||||||||
|
Abbott Resource Report Resource Website 1000+ mentions |
Abbott (RRID:SCR_010477) | ABT | commercial organization | An American pharmaceuticals and health care products company that since splitting into Abbott and AbbVie, focuses on diversified medical products. (AbbVie focuses on research-based pharmaceuticals) It has 90,000 employees and operates in over 130 countries. The company headquarters are in Abbott Park, North Chicago, Illinois. (adapted from Wikipedia) | medical product |
is related to: AbbVie is related to: AbbVie |
grid.487133.a, nlx_158066, Wikidata:Q41568647, ISNI:0000 0004 0613 6646 | https://ror.org/04x0p4p48 | SCR_010477 | Abbott Laboratories | 2026-08-29 11:23:43 | 1689 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
Welcome to the Neuroscience Information Framework Project, designed to serve the biomedical research community. NIF maintains the largest searchable collection of neuroscience data, the largest catalog of biomedical resources, and the largest ontology for neuroscience on the web. We welcome all feedback and suggestions and are actively looking for resource providers to make their resources accessible through NIF. Learn about the tools available to help you share your data and discover a dynamic inventory of Web-based neuroscience resources.
